Nuzenio

Elvn

Elvn news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 9 publisher sources 100/100 entity strength

Latest news

LifeSci Capital Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Maintains Target Price $70 - MoomooMoomoo · Sat, 08 Aug 2026 14:31:00 GMTLifeSci Capital Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Raises Target Price to $70 - MoomooMoomoo · Sat, 08 Aug 2026 03:55:41 GMTEnliven Therapeutics (ELVN) director exercises options, sells 158,795 shares - Stock TitanStock Titan · Fri, 07 Aug 2026 02:15:04 GMTInsider Sale: Director at $ELVN Sells 158,795 Shares - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 00:32:00 GMTA Quick Look at Today's Ratings for Enliven Therapeutics(ELVN.US), With a Forecast Between $68 to $82 - MoomooMoomoo · Thu, 06 Aug 2026 22:49:06 GMTFMR LLC and Abigail Johnson disclose 15% Enliven Therapeutics (ELVN) ownership - Stock TitanStock Titan · Thu, 06 Aug 2026 14:21:20 GMTThe Goldman Sachs Group Raises Enliven Therapeutics (NASDAQ:ELVN) Price Target to $80.00 - MarketBeatMarketBeat · Thu, 06 Aug 2026 12:39:34 GMTENLIVEN THERAPEUTICS, INC. : JEFFERIES RAISES TARGET PRICE TO $69 FROM $59 - BitgetBitget · Wed, 05 Aug 2026 22:08:03 GMT

Timeline

Sat, 08 Aug 2026 14:31:00 GMTLifeSci Capital Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Maintains Target Price $70 - Moomoo
Sat, 08 Aug 2026 03:55:41 GMTLifeSci Capital Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Raises Target Price to $70 - Moomoo
Fri, 07 Aug 2026 02:15:04 GMTEnliven Therapeutics (ELVN) director exercises options, sells 158,795 shares - Stock Titan
Fri, 07 Aug 2026 00:32:00 GMTInsider Sale: Director at $ELVN Sells 158,795 Shares - Quiver Quantitative
Thu, 06 Aug 2026 22:49:06 GMTA Quick Look at Today's Ratings for Enliven Therapeutics(ELVN.US), With a Forecast Between $68 to $82 - Moomoo
Thu, 06 Aug 2026 14:21:20 GMTFMR LLC and Abigail Johnson disclose 15% Enliven Therapeutics (ELVN) ownership - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Elvn.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.